Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021.
Options
BORIS DOI
Publisher DOI
PubMed ID
34723783
Description
Incidence of invasive pneumococcal disease (IPD) has been low during the peak of the COVID-19 pandemic. In this study, we found that the IPD numbers again increased in Switzerland during the first six months of 2021, and that this coincides with the loosening of COVID 19 measures.Vaccine pneumococcal serotypes have continued to decrease but non-vaccine type serotype 23B has emerged (8% of the isolates in 2021). Worryingly, serotype 23B is associated with reduced susceptibility to penicillin.
Date of Publication
2021-12
Publication Type
Article
Subject(s)
500 - Science::570 - Life sciences; biology
600 - Technology::610 - Medicine & health
Keyword(s)
COVID-19 restrictions Streptococcus pneumoniae non-susceptibility to penicillin surveillance
Language(s)
en
Contributor(s)
Additional Credits
Institut für Infektionskrankheiten (IFIK)
Institut für Infektionskrankheiten, Forschung
Institut für Infektionskrankheiten, Allgemeine Bakteriologie
Series
Emerging microbes & infections
Publisher
Taylor & Francis
ISSN
2222-1751
Access(Rights)
open.access